Relay Therapeutics, Inc. Common Stock (RLAY) is a publicly traded Healthcare sector company. As of May 19, 2026, RLAY trades at $13.42 with a market cap of $2.34B and a P/E ratio of -7.54. RLAY moved -0.86% today. Year to date, RLAY is +47.92%; over the trailing twelve months it is +330.61%. Its 52-week range spans $1.78 to $17.32. Analyst consensus is strong buy with an average price target of $20.78. Rallies surfaces RLAY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Relay Therapeutics, Inc. Common Stock (RLAY) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. RLAY moved -0.86% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $13.42 |
| Market Cap | $2.34B |
| P/E Ratio | -7.54 |
| EPS | $-1.56 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.32 |
| 52-Week Low | $1.78 |
| Volume | 1.22M |
| Avg Volume | 0 |
| Revenue (TTM) | $10.68M |
| Net Income | $-272.70M |
| Gross Margin | 0.00% |
10 analysts cover RLAY: 0 strong buy, 9 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $20.78.